Adolore Biotherapeutics, Inc. | WebDisclosure

Switch to English

10074	Sociétés
206005	Mots-clés
136248	Articles
109221	Communiqués

Accueil
Sociétés
Adolore Biotherapeutics, Inc.

COMMUNIQUÉ DE PRESSE

publié le 16/05/2024 à 16:00, il y a 1 année 10 mois

Adolore BioTherapeutics Announces Publication Demonstrating Carbonic Anhydrase-8 Gene Therapy (rdHSV-CA8) Decreased Pain-Sensing Neuronal Excitability by Activating Kv7 Voltage-Gated Potassium Channels
Adolore BioTherapeutics announces groundbreaking findings in gene therapy for chronic pain treatment, highlighting the value of non-opioid analgesics and progress with IND-enabling studies

Adolore BioTherapeutics Chronic Pain Gene Therapy Non-opioid Analgesics IND-enabling Studies
BRÈVE

publiée le 04/03/2024 à 16:05, il y a 2 années

Adolore BioTherapeutics obtient un brevet américain pour la thérapie génique CA8* dans le traitement de la douleur chronique

Adolore BioTherapeutics Thérapie Génique Traitement De La Douleur Chronique Solutions Sans Opioïdes Délivrance De Brevet
BRÈVE

publiée le 04/03/2024 à 16:05, il y a 2 années

Adolore BioTherapeutics Secures U.S. Patent for CA8* Gene Therapy in Chronic Pain Treatment

Adolore BioTherapeutics Gene Therapy Chronic Pain Treatment Opioid-Free Solutions Patent Issuance
COMMUNIQUÉ DE PRESSE

publié le 04/03/2024 à 16:00, il y a 2 années

Adolore BioTherapeutics Announces Issuance of First U.S. Patent Covering CA8* Gene Therapies to Treat Chronic Pain
Adolore BioTherapeutics licenses patent and CA8* gene therapy technology from the University of Miami for opioid-free chronic pain treatment. Company progresses toward clinical testing and commercialization

University Of Miami Adolore BioTherapeutics Chronic Pain Opioid-free Gene Therapy
COMMUNIQUÉ DE PRESSE

publié le 30/01/2024 à 16:00, il y a 2 années 1 mois

Adolore BioTherapeutics to Present at the 5th Annual National Institutes of Health (NIH) HEAL Initiative Scientific Meeting
Adolore BioTherapeutics will present at the 5th Annual NIH HEAL Initiative Scientific Meeting regarding the gene therapy program for chronic pain associated with knee osteoarthritis. The program is supported by NIH/NINDS HEAL UH3 Award

Adolore BioTherapeutics Chronic Pain NIH HEAL Initiative Gene Therapy Osteoarthritis
COMMUNIQUÉ DE PRESSE

publié le 05/12/2023 à 16:30, il y a 2 années 3 mois

Adolore BioTherapeutics Presents Promising Preclinical Data Supporting Its Innovative Gene Therapy to Treat Chronic Pain
Adolore BioTherapeutics presented preclinical data supporting its innovative CA8* gene therapy as a long-acting local analgesic for chronic osteoarthritis knee pain management, aiming to replace opioids

Adolore BioTherapeutics CA8* Gene Therapy Chronic Pain Opioid-free Preclinical Data
COMMUNIQUÉ DE PRESSE

publié le 11/10/2023 à 16:00, il y a 2 années 5 mois

Adolore BioTherapeutics to Participate at the Virtual Investor Ask the CEO Conference
COMMUNIQUÉ DE PRESSE

publié le 03/10/2023 à 15:15, il y a 2 années 5 mois

NIN/NINDS HEAL Program Grants Prestigious UH3 Award to the University of Miami, Principal Investigator Roy C. Levitt M.D, to Fund Clinical Development of Adolore BioTherapeutics’ Gene Therapy Program for the Treatment of Chronic Osteoarthritis Knee Pain

Les Echos

Publié le 24/03/2026 à 10:58, il y a 1 heure 18 minutes

Statement about the number of shares composing the share capital and the number of voting rights as of February 28, 2026
Publié le 24/03/2026 à 10:58, il y a 1 heure 18 minutes

Déclaration du nombre d'actions composant le capital social et du nombre total de droits de vote au 28 février 2026
Publié le 24/03/2026 à 07:45, il y a 4 heures 31 minutes

François Jackow’s appointment as a Board member will be submitted to the Annual General Meeting on May 7, 2026
Publié le 24/03/2026 à 07:45, il y a 4 heures 31 minutes

La nomination de François Jackow en tant que membre du Conseil d’administration sera soumise à l’Assemblée générale du 7 mai 2026
Publié le 24/03/2026 à 07:30, il y a 4 heures 46 minutes

Gimv secures new EUR 400 million revolving credit facility to support accelerated growth ambitions

Voir tout LES ECHOS COMFI WIRE

Accesswire

Publié le 24/03/2026 à 12:05, il y a 11 minutes

Faraday Copper Continues to Intersect Near-Surface Copper Mineralization at American Eagle and Expands Keel Laterally
Publié le 24/03/2026 à 10:10, il y a 2 heures 6 minutes

BioNxt Enters Commercialization Phase with Global Patent Protection and U.S. Fast Track Strategy for Sublingual Drug Delivery Platform
Publié le 24/03/2026 à 08:01, il y a 4 heures 15 minutes

Star Copper Confirms Copper Creek Mineralization
Publié le 24/03/2026 à 07:00, il y a 5 heures 16 minutes

Panther Minerals Earns In Under Rubidium Ridge Project Option
Publié le 24/03/2026 à 07:00, il y a 5 heures 16 minutes

Panther Completes Acquisition of Rubidium Ridge Project

Voir tout ACCESSWIRE

EQS Group

Publié le 24/03/2026 à 11:59, il y a 17 minutes

Vienna Soil Dialogue: AGRANA shifts focus to soil as a strategic resource key to Europe’s future
Publié le 24/03/2026 à 11:45, il y a 31 minutes

BIOTRONIK Leaps Forward with Next‑Generation Leadless Pacing
Publié le 24/03/2026 à 11:32, il y a 44 minutes

Correction of a release from 24.03.2026 08:00 GMT/BST - official list notice
Publié le 24/03/2026 à 11:30, il y a 46 minutes

Infosys and University of Nottingham Extend Strategic Collaboration to Strengthen Digital Infrastructure for Student Management System
Publié le 24/03/2026 à 11:20, il y a 56 minutes

EQS-Adhoc: Leifheit Aktiengesellschaft: Dividend Proposal and Forecast for Financial Year 2026